Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China flag China · Delayed Price · Currency is CNY
36.79
+0.41 (1.13%)
May 12, 2026, 3:00 PM CST

SHA:603590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
332.57189.98230.2345.25599.08
Short-Term Investments
-53.82183.820.7510.81
Trading Asset Securities
500.43450.66396.41280.379.04
Cash & Short-Term Investments
833694.46810.43626.36618.93
Cash Growth
19.95%-14.31%29.39%1.20%-59.49%
Accounts Receivable
278.09257.38282.83296.39244.38
Other Receivables
76.0733.8435.5627.736.31
Receivables
354.16291.22318.39324.13250.69
Inventory
54.4772.3848.4736.9947.02
Other Current Assets
153.928.4852.6729.2331.19
Total Current Assets
1,3961,0871,2301,017947.83
Property, Plant & Equipment
404.15426.73414.54440.14407.06
Long-Term Investments
1,0251,249984.45927.15695.95
Goodwill
--97.6497.6497.64
Other Intangible Assets
833.37842.67854.64812.75815.17
Long-Term Deferred Tax Assets
21.3627.4732.271.098.96
Long-Term Deferred Charges
308234.36150.71120.4582.41
Other Long-Term Assets
107.3453.3116.68.87316.3
Total Assets
4,0953,9203,7813,4253,371
Accounts Payable
31.273.5782.9748.4746.74
Accrued Expenses
50.0145.6832.1526.8233.99
Short-Term Debt
253.45140.9696.93--
Current Portion of Long-Term Debt
9.251.075.12--
Current Portion of Leases
-73.958.717.5
Current Income Taxes Payable
11.694.690.2534.1215.84
Current Unearned Revenue
5.956.436.492.921.2
Other Current Liabilities
97.8973.2995.5351.3249.49
Total Current Liabilities
459.45352.68323.39172.36154.77
Long-Term Debt
54.2849.8543.78--
Long-Term Leases
3.1710.8-3.7111.12
Long-Term Unearned Revenue
41.8740.4823.4928.9829.83
Long-Term Deferred Tax Liabilities
39.7439.7227.7829.6245.02
Total Liabilities
598.51493.52418.44234.68240.74
Common Stock
159.01159.36160160160
Additional Paid-In Capital
948.77944.6955.01992.46985.17
Retained Earnings
2,1152,0452,0501,9311,876
Treasury Stock
-32.86-35.93-78.59-124.64-124.64
Comprehensive Income & Other
21.1431.8-26.5-32.8-8.11
Total Common Equity
3,2113,1443,0602,9262,889
Minority Interest
285.21281.75302.44264.22241.81
Shareholders' Equity
3,4963,4263,3623,1903,131
Total Liabilities & Equity
4,0953,9203,7813,4253,371
Total Debt
320.16209.67149.7812.4218.62
Net Cash (Debt)
512.84484.79660.65613.94600.31
Net Cash Growth
5.79%-26.62%7.61%2.27%-60.08%
Net Cash Per Share
3.213.104.223.933.81
Filing Date Shares Outstanding
158.63159.22158.98156.49156.49
Total Common Shares Outstanding
158.63158.83158.98156.49156.49
Working Capital
936.08733.86906.57844.35793.06
Book Value Per Share
20.2419.8019.2518.7018.46
Tangible Book Value
2,3782,3022,1082,0161,976
Tangible Book Value Per Share
14.9914.4913.2612.8812.63
Buildings
-324.61322.64323.38322.3
Machinery
-126.83125.74126.76114.72
Construction In Progress
-209.85190.8181.98127.26
Source: S&P Global Market Intelligence. Standard template. Financial Sources.